產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
HOS (人骨肉瘤細(xì)胞)(STR鑒定正確）
貨號(hào)：CL-0360
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價(jià)格： ￥1400
生長(zhǎng)培養(yǎng)基：MEM（含NEAA）＋10% FBS＋1% P/S
產(chǎn)品概述
| 名稱 | HOS (人骨肉瘤細(xì)胞)(STR鑒定正確） |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 成纖維細(xì)胞、上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | HOS細(xì)胞是從一名13歲的白人女性的骨肉瘤組織中分離建立的；HOS細(xì)胞表現(xiàn)為扁平形態(tài)、低飽和密度、軟瓊脂中的低克隆形成率和對(duì)化合物及病毒感染的敏感性。 |
| 年齡（性別） | 女性；13歲 |
| 組織來源 | 骨；骨肉瘤 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 肉瘤細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 保藏機(jī)構(gòu) | ATCC; CRL-1543 ECACC; 87070202 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 12 D2S1338 24,25 D3S1358 15 D5S818 13 D7S820 11,12 D8S1179 14 D13S317 12 D16S539 10,13 D18S51 14 D19S433 13 D21S11 31.2,32.2 FGA 24 PentaD 9,10 PentaE 7,12 TH01 6 TPOX 8,11 vWA 18 D6S1043 18 D12S391 20 D2S441 10 -
STR鑒定圖
-
參考文獻(xiàn)
-
DUSP3 restrains the progression and stemness property of osteosarcoma through regulating EGFR/STAT3/SOX2 axis (2025-01-01)
期刊：International Journal of Biological Sciences
影響因子 ：8.2
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , MG-63 細(xì)胞 , HOS 細(xì)胞
-
Prognostic model of osteosarcoma based on telomere-related genes and analysis of immune characteristics (2025-02-20)
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2025.114198
影響因子 ：4.8
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞
-
A telomere-related signature for predicting prognosis and assessing immune microenvironment in osteosarcoma (2025-01-27)
期刊：Frontiers in Pharmacology
DOI：10.3389/fphar.2024.1532610
影響因子 ：4.4
引用產(chǎn)品： HOS 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , DMEM無糖 培養(yǎng)基 , MEM（含NEAA） 培養(yǎng)基 , McCoy's 5A 培養(yǎng)基
-
Exosome-Delivered Hsa_Circ_0000116 Facilitates Osteosarcoma Cell Malignancy via PI3K/Akt/mTOR and p38/MAPK Pathways (2025-01-08)
期刊：DNA AND CELL BIOLOGY
影響因子 ：2.6
引用產(chǎn)品： HOS 細(xì)胞 , MG-63 細(xì)胞 , MEM 培養(yǎng)基 , 特級(jí)胎牛血清
-
pH-responsive paclitaxel prodrug encapsulated in a polypeptide-chitosan polymer delivery system for osteosarcoma treatment (2025-02-04)
期刊：CARBOHYDRATE RESEARCH
DOI：10.1016/j.carres.2025.109414
影響因子 ：2.4
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞
-
Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating P38/JNK Signaling Pathway (2024-02-01)
期刊：International Journal of Nanomedicine
影響因子 ：8.0
引用產(chǎn)品： HOS 細(xì)胞 , MG-63 細(xì)胞
-
Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression (2024-02-15)
期刊：PHYTOMEDICINE
DOI：10.1016/j.phymed.2024.155459
影響因子 ：7.9
引用產(chǎn)品： HOS 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞 , DMEM高糖 培養(yǎng)基
-
Ziyuglycoside II, a triterpene glycoside compound in Sanguisorbae officinalis L. extract, suppresses metastasis in osteosarcoma via CBX4-mediated Wnt/β-catenin signal pathway (2024-05-09)
期刊：PHYTOMEDICINE
DOI：10.1016/j.phymed.2024.155716
影響因子 ：7.9
引用產(chǎn)品： MG-63 細(xì)胞 , HOS 細(xì)胞
-
Multi-omics analysis reveals cuproptosis and mitochondria-based signature for assessing prognosis and immune landscape in osteosarcoma (2024-01-05)
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1280945
影響因子 ：7.3
引用產(chǎn)品： hFOB 1.19 細(xì)胞 , HOS 細(xì)胞 , Saos-2 細(xì)胞 , 143B 細(xì)胞
-
Deubiquitinase USP10 promotes osteosarcoma autophagy and progression through regulating GSK3β-ULK1 axis (2024-09-02)
期刊：Cell and Bioscience
DOI：10.1186/s13578-024-01291-9
影響因子 ：6.1
引用產(chǎn)品： MEM 培養(yǎng)基 , HOS 細(xì)胞
-
What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance (2024-01-13)
期刊：Cancer Cell International
DOI：10.1186/s12935-024-03216-5
影響因子 ：5.8
引用產(chǎn)品： McCoy's 5A 培養(yǎng)基 , DMEM高糖 培養(yǎng)基 , U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞
-
A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma (2024-11-06)
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2024.1467052
影響因子 ：5.7
引用產(chǎn)品： hFOB 1.19 細(xì)胞 , HOS 細(xì)胞 , 143B 細(xì)胞
-
Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation (2024-04-24)
期刊：Frontiers in Pharmacology
DOI：10.3389/fphar.2024.1399625
影響因子 ：5.6
引用產(chǎn)品： MG-63 細(xì)胞 , hFOB 1.19 細(xì)胞 , HOS 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞
-
Cytotoxic and Antibacterial Meroterpenoids Isolated from the Marine-Derived Fungus Talaromyces sp. M27416 (2024-04-20)
期刊：Marine Drugs
影響因子 ：5.4
引用產(chǎn)品： K-562 [K562] 細(xì)胞 , TE-1 細(xì)胞 , HOS 細(xì)胞 , GBC-SD 細(xì)胞 , PaTu 8988t 細(xì)胞 , DU 145 細(xì)胞 , 293T [HEK-293T] 細(xì)胞 , SF126 細(xì)胞 , MCF7 [MCF-7] 細(xì)胞 , HCT 116 細(xì)胞 , Hela 細(xì)胞 , A549 [A-549] 細(xì)胞 , Hep G2 細(xì)胞 , A-375 細(xì)胞 , MKN-45 細(xì)胞 , 5637 細(xì)胞 , 786-O [786-0] 細(xì)胞 , CAL-62 細(xì)胞 , A-673 細(xì)胞 , HL-7702 [L-02; LO2] 細(xì)胞
-
The expression and clinical significance of ARHGAP25 in osteosarcoma based on bioinformatics analysis (2024-08-12)
期刊：Scientific Reports
DOI：10.1038/s41598-024-68318-6
影響因子 ：3.8
引用產(chǎn)品： MG-63 細(xì)胞 , HOS 細(xì)胞 , hFOB 1.19 細(xì)胞
-
A GAD1 inhibitor suppresses osteosarcoma growth through the Wnt/β-catenin signaling pathway (2024-05-17)
期刊：Heliyon
DOI：10.1016/j.heliyon.2024.e31444
影響因子 ：3.4
引用產(chǎn)品： HOS 細(xì)胞 , MG-63 細(xì)胞 , 143B 細(xì)胞
-
WTAP-mediated m6A modification of circ_0032463 promotes osteosarcoma progression by sponging miR-145-5p and regulating GFRA1 expression (2024-09-07)
期刊：JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
影響因子 ：3.2
引用產(chǎn)品： HOS 細(xì)胞 , hFOB 1.19 細(xì)胞 , U-2 OS [U2OS]細(xì)胞專用培養(yǎng)基 , 人臍靜脈內(nèi)皮細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , HOS細(xì)胞專用培養(yǎng)基
-
Distinct Gene Expression and Immune Features Between Different Neutrophil Extracellular Trap-Related Osteosarcoma Subtypes (2024-08-03)
期刊：APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
DOI：10.1007/s12010-024-05021-2
影響因子 ：3.1
引用產(chǎn)品： MEM（含NEAA） 培養(yǎng)基 , 特級(jí)胎牛血清 , U-2 OS [U2OS] 細(xì)胞 , McCoy's 5A 培養(yǎng)基 , HOS 細(xì)胞
-
Circ_0049271 targets the miR-1197/PTRF axis to attenuate the malignancy of osteosarcoma (2024-02-27)
期刊：Cancer Biomarkers
影響因子 ：2.2
引用產(chǎn)品： hFOB 1.19 細(xì)胞 , HOS 細(xì)胞 , Saos-2 細(xì)胞 , 特級(jí)胎牛血清 , McCoy's 5A 培養(yǎng)基 , DMEM高糖 培養(yǎng)基 , Leibovitz's L-15 培養(yǎng)基
-
MiR-150-5p inhibits cell proliferation and metastasis by targeting FTO in osteosarcoma (2024-10-16)
期刊：ONCOLOGY RESEARCH
影響因子 ：2.0
引用產(chǎn)品： MG-63 細(xì)胞 , HOS 細(xì)胞 , Saos-2 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , hFOB 1.19 細(xì)胞
-
Momordin Ic Inhibits the Partially Malignant Phenotype of Osteosarcoma Cells by Inducing Apoptosis and Autophagy (2024-02-07)
期刊：Natural Product Communications
影響因子 ：1.8
引用產(chǎn)品： HOS 細(xì)胞 , 143B 細(xì)胞
-
MFAP2 induces epithelial-mesenchymal transformation of osteosarcoma cells by activating the Notch1 pathway (2024-06-27)
期刊：Translational Cancer Research
影響因子 ：1.5
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞 , hFOB 1.19 細(xì)胞 , MG-63 細(xì)胞
-
Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction (2023-12-15)
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1265098
影響因子 ：7.3
引用產(chǎn)品： HOS 細(xì)胞 , Saos-2 細(xì)胞
-
A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes (2023-04-06)
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1150588
影響因子 ：7.3
引用產(chǎn)品： 143B 細(xì)胞 , HOS 細(xì)胞
-
A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function (2023-10-03)
期刊：EXPERT OPINION ON THERAPEUTIC TARGETS
DOI：10.1080/14728222.2023.2263908
影響因子 ：5.8
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , Saos-2 細(xì)胞 , MG-63 細(xì)胞 , HOS 細(xì)胞 , SJSA-1 細(xì)胞 , hFOB 1.19 細(xì)胞 , McCoy's 5A 培養(yǎng)基 , MEM 培養(yǎng)基 , RPMI-1640 培養(yǎng)基 , DMEM/F12 培養(yǎng)基
-
Solasonine Inhibits Cancer Stemness and Metastasis by Modulating Glucose Metabolism via Wnt/β-Catenin/Snail Pathway in Osteosarcoma (2023-06-28)
期刊：AMERICAN JOURNAL OF CHINESE MEDICINE
影響因子 ：5.7
引用產(chǎn)品： HOS 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞
-
Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma (2023-01-09)
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2023.109684
影響因子 ：5.6
引用產(chǎn)品： HOS 細(xì)胞 , MG-63 細(xì)胞 , hFOB 1.19 細(xì)胞
-
ATRX loss suppresses the type I interferon response in sarcoma cells through chromatin remodeling (2023-08-15)
期刊：American Journal of Cancer Research
DOI：PMID:37693131
影響因子 ：5.3
引用產(chǎn)品： HOS 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , Saos-2 細(xì)胞 , 293T [HEK-293T] 細(xì)胞 , MG-63 細(xì)胞
-
Circular RNA hsa_circ_001350 contributes to osteosarcoma progression by regulating microRNA-578/CCR4-NOT transcription complex and subunit 7/Wnt signaling (2023-06-15)
期刊：American Journal of Cancer Research
DOI：PMID:37424831
影響因子 ：5.3
引用產(chǎn)品： hFOB 1.19 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞 , Saos-2 細(xì)胞 , MG-63 細(xì)胞
-
HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the PTEN/PI3K/AKT pathway (2023-07-30)
期刊：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
DOI：10.1016/j.bbamcr.2023.119553
影響因子 ：5.1
引用產(chǎn)品： HOS 細(xì)胞 , Saos-2 細(xì)胞 , SW 1353 細(xì)胞 , McCoy's 5A 培養(yǎng)基
-
Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment (2023-06-08)
期刊：Frontiers in Oncology
影響因子 ：4.7
引用產(chǎn)品： MG-63 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞 , RAW 264.7 細(xì)胞
-
WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner (2023-03-29)
期刊：ENVIRONMENTAL TOXICOLOGY
影響因子 ：4.5
引用產(chǎn)品： DMEM/F12 培養(yǎng)基 , 特級(jí)胎牛血清 , MEM 培養(yǎng)基 , hFOB 1.19 細(xì)胞 , McCoy's 5A 培養(yǎng)基 , HOS 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , 青霉素-鏈霉素溶液（雙抗），100×
-
hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression (2023-11-18)
期刊：CANCER BIOLOGY & THERAPY
DOI：10.1080/15384047.2023.2274120
影響因子 ：3.6
引用產(chǎn)品： hFOB 1.19 細(xì)胞 , HOS 細(xì)胞 , Saos-2 細(xì)胞 , SW 1353 細(xì)胞 , Leibovitz's L-15 培養(yǎng)基 , McCoy's 5A完全培養(yǎng)基 (含10%FBS） , MEM 培養(yǎng)基 , DMEM/F12 培養(yǎng)基 , 青霉素-鏈霉素溶液 (雙抗)，100× , 特級(jí)胎牛血清
-
Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis, immune characteristics, and therapeutic response (2023-05-12)
期刊：Journal of Bone Oncology
影響因子 ：3.4
引用產(chǎn)品： HOS 細(xì)胞 , MG-63 細(xì)胞 , hFOB 1.19 細(xì)胞
-
Hsa_circ_0000591 drives osteosarcoma glycolysis and progression by sequestering miR-194-5p and elevating HK2 expression (2023-02-21)
期刊：CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
影響因子 ：2.9
引用產(chǎn)品： HOS 細(xì)胞 , MG-63 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , 青霉素-鏈霉素溶液 (雙抗)，100× , hFOB 1.19 細(xì)胞
-
Farnesyl diphosphate synthase promotes cell proliferation by regulating gene expression and alternative splicing profiles in HeLa cells (2023-02-28)
期刊：Oncology Letters
影響因子 ：2.9
引用產(chǎn)品： Hela S3 細(xì)胞 , HOS 細(xì)胞 , MEM (含NEAA) 培養(yǎng)基
-
Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy (2023-11-22)
期刊：Journal of Orthopaedic Surgery and Research
DOI：10.1186/s13018-023-04338-8
影響因子 ：2.6
引用產(chǎn)品： MG-63 細(xì)胞 , HOS 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , Saos-2 細(xì)胞
-
ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells (2023-11-29)
期刊：Journal of Orthopaedic Surgery and Research
DOI：10.1186/s13018-023-04406-z
影響因子 ：2.6
引用產(chǎn)品： MG-63 細(xì)胞 , HOS 細(xì)胞 , hFOB 1.19 細(xì)胞 , MEM 培養(yǎng)基 , DMEM高糖 培養(yǎng)基 , G-418溶液 (50mg/mL)
-
Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma (2022-12-23)
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2022.1096009
影響因子 ：8.8
引用產(chǎn)品： MG-63 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , Saos-2 細(xì)胞 , HOS 細(xì)胞 , hFOB 1.19 細(xì)胞
-
Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature (2022-10-14)
期刊：Frontiers in Endocrinology
DOI：10.3389/fendo.2022.1030655
影響因子 ：6.1
引用產(chǎn)品： HOS 細(xì)胞
-
CKB affects human osteosarcoma progression by regulating the p53 pathway (2022-10-15)
期刊：American Journal of Cancer Research
DOI：PMID:36381321
影響因子 ：5.9
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , hFOB 1.19 細(xì)胞 , Saos-2 細(xì)胞 , HOS 細(xì)胞 , MG-63 細(xì)胞
-
Circular RNA circDOCK1 contributes to osteosarcoma progression by acting as a ceRNA for miR-936 to regulate LEF1 (2022-09-09)
期刊：Journal of Bone Oncology
影響因子 ：4.5
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞 , U-2 OS [U2OS]細(xì)胞專用培養(yǎng)基 , HOS細(xì)胞專用培養(yǎng)基 , hFOB 1.19 細(xì)胞 , 青霉素-鏈霉素溶液 (雙抗)，100× , 人臍靜脈內(nèi)皮細(xì)胞
-
Hsa_circ_0097271 Knockdown Attenuates Osteosarcoma Progression via Regulating miR-640/MCAM Pathway (2022-10-26)
期刊：DISEASE MARKERS
影響因子 ：3.5
引用產(chǎn)品： HOS 細(xì)胞
-
A New 7-Azaindole Structure Analog: Molecular Docking, Synthesis and Preliminary Biological Activity in Vitro for Anticancer (2022-09-09)
期刊：CHEMISTRY & BIODIVERSITY
影響因子 ：2.8
引用產(chǎn)品： NCTC clone 929 [L 細(xì)胞, L-929] 細(xì)胞 , HOS 細(xì)胞
-
Circ_0003732 promotes osteosarcoma progression through regulating miR-377-3p/CPEB1 axis and Wnt/β-catenin signaling pathway (2022-01-01)
期刊：Anti-Cancer Drugs
DOI：10.1097/CAD.0000000000001206
影響因子 ：2.4
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞 , hFOB 1.19 細(xì)胞
-
lncRNA MELTF-AS1 facilitates osteosarcoma metastasis by modulating MMP14 expression (2021-08-26)
期刊：Molecular Therapy-Nucleic Acids
DOI：10.1016/j.omtn.2021.08.022
影響因子 ：8.8
引用產(chǎn)品： Saos-2 細(xì)胞 , MG-63 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞
-
Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9 (2021-07-14)
期刊：Cancer Cell International
DOI：10.1186/s12935-021-02041-4
影響因子 ：5.8
引用產(chǎn)品： HOS 細(xì)胞 , MG-63 細(xì)胞 , DMEM高糖完全培養(yǎng)基 (含10%FBS)
-
circATP2A2 promotes osteosarcoma progression by upregulating MYH9 (2021-11-22)
期刊：Open Medicine
影響因子 ：2.1
引用產(chǎn)品： U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞 , Saos-2 細(xì)胞 , 特級(jí)胎牛血清 , DMEM/F12 培養(yǎng)基 , hFOB 1.19 細(xì)胞
-
Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells (2021-10-18)
期刊：Oxidative Medicine and Cellular Longevity
影響因子 ：0.0
引用產(chǎn)品： MG-63 細(xì)胞 , HOS 細(xì)胞
-
A novel photothermally controlled multifunctional scaffold for clinical treatment of osteosarcoma and tissue regeneration (2020-06-01)
期刊：Materials Today
DOI：10.1016/j.mattod.2019.12.005
影響因子 ：24.2
引用產(chǎn)品： MC3T3-E1 Subclone 14 細(xì)胞 , HOS 細(xì)胞
-
ADAM10 promotes cell growth, migration, and invasion in osteosarcoma via regulating E-cadherin/β-catenin signaling pathway and is regulated by miR-122-5p (2020-03-30)
期刊：Cancer Cell International
DOI：10.1186/s12935-020-01174-2
影響因子 ：5.8
引用產(chǎn)品： Saos-2 細(xì)胞 , SW 1353 細(xì)胞 , HOS 細(xì)胞 , McCoy's 5A 培養(yǎng)基
-
Antitumor Effect of miR-1294/Pyruvate Kinase M2 Signaling Cascade in Osteosarcoma Cells (2020-02-21)
期刊：OncoTargets and Therapy
影響因子 ：4.0
引用產(chǎn)品： Saos-2 細(xì)胞 , HOS 細(xì)胞
-
COLEC12 regulates apoptosis of osteosarcoma through Toll-like receptor 4–activated inflammation (2020-08-21)
期刊：JOURNAL OF CLINICAL LABORATORY ANALYSIS
影響因子 ：1.5
引用產(chǎn)品： hFOB 1.19 細(xì)胞 , MG-63 細(xì)胞 , Saos-2 細(xì)胞 , HOS 細(xì)胞
-
Sirt1 modulates H3 phosphorylation and facilitates osteosarcoma cell autophagy (2019-08-07)
期刊：Artificial Cells Nanomedicine and Biotechnology
DOI：10.1080/21691401.2019.1648280
影響因子 ：5.8
引用產(chǎn)品： Saos-2 細(xì)胞 , MG-63 細(xì)胞 , HOS 細(xì)胞
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識(shí)別碼示意圖
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
